JW (Cayman) Therapeutics Co. Ltd (HKG:2126)
Hong Kong · Delayed Price · Currency is HKD 2.720
+0.240 (9.68%)
May 7, 2026, 4:08 PM HKT
HKG:2126 Market Cap
HKG:2126 has a market cap or net worth of 1.1 billion as of May 7, 2026. Its market cap has increased by 83.95% in one year.
Market Cap
1.10B
Enterprise Value
835.53M
Revenue
315.65M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.72
Market Cap Chart
Since November 3, 2020, HKG:2126's market cap has decreased from 8.28B to 1.10B, a decrease of -86.67%. That is a compound annual growth rate of -30.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2026 | 1.10B | 8.37% |
| Dec 31, 2025 | 1.02B | 96.55% |
| Dec 31, 2024 | 518.01M | -42.89% |
| Dec 29, 2023 | 907.01M | -47.90% |
| Dec 30, 2022 | 1.74B | -67.36% |
| Dec 31, 2021 | 5.33B | -47.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kintor Pharmaceutical | 1.58B |
| CANbridge Pharmaceuticals | 1.18B |
| Shanghai Bio-heart Biological Technology | 1.11B |
| Sunho Biologics | 970.43M |
| Transcenta Holding | 962.77M |
| Brii Biosciences | 959.94M |
| Wuhan YZY Biopharma | 891.71M |
| 3D Medicines | 885.84M |